What Is RDW-CV in a Blood Test & What Do the Results Mean?

RDW-CV stands for Red Cell Distribution Width–Coefficient of Variation, and it measures how much your red blood cells vary in size. A normal result usually falls between about 11.5% and 14.5%, though exact reference ranges differ slightly between laboratories. When the number is elevated, it tells your doctor that your red blood cells are coming in a wider-than-usual mix of sizes, a condition called anisocytosis, which can point to anything from a simple iron deficiency to chronic inflammatory disease. The value itself is not a diagnosis, but it is one of the most useful screening clues tucked inside a routine complete blood count.

How RDW-CV Is Calculated

Every time a blood sample runs through a hematology analyzer, the machine measures millions of individual red blood cells and records their volumes. Those volumes form a distribution curve. RDW-CV captures how spread out that curve is, expressed as a percentage. The formula divides the standard deviation of red blood cell volume by the mean corpuscular volume (MCV), then multiplies by 100.¹ In plain terms, a result of 13% means the typical spread in cell size is 13% of the average cell volume. A result of 18% means cells are ranging much more widely around that average.

Because MCV sits in the denominator, RDW-CV is a relative measure. That matters clinically: if your cells are uniformly tiny or uniformly large, RDW-CV can still be normal, because the spread around the mean stays tight even though the mean itself is abnormal. This is why doctors almost always read RDW-CV alongside MCV rather than in isolation.

RDW-CV Versus RDW-SD

Your lab report might list RDW-CV, RDW-SD, or both. RDW-CV is the more commonly reported of the two and is based on the coefficient of variation, making it dependent on MCV. RDW-SD, by contrast, is a direct measurement of the width of the red blood cell distribution curve in femtoliters and is not influenced by MCV.² A normal RDW-SD is roughly 39 to 46 femtoliters.

The practical difference shows up in a few situations. Because RDW-CV is divided by MCV, a patient whose MCV is very low can get a deceptively high RDW-CV even if the absolute spread in cell sizes is only modest. RDW-SD avoids that math problem because it reads the spread directly from the histogram. In chronic kidney disease, for example, researchers have noted that both measures tend to track together and reflect chronic disease status rather than short-term changes from a single dialysis session.³ Still, most routine labs in the United States and Europe report RDW-CV by default, which is why it is the version you are most likely to encounter on your own results.

What a Normal Result Looks Like

Most adult reference ranges place normal RDW-CV somewhere between 11.5% and 14.5%. If your result falls within that window, your red blood cells are fairly uniform in size. That uniformity is what healthy, steady-state red blood cell production looks like: the bone marrow is churning out cells at a consistent pace, the cells are getting enough raw materials (iron, folate, vitamin B12), and old cells are being cleared on schedule.

A result right at the upper edge of normal is not necessarily alarming, but it is worth putting in context. Some labs set their upper limit at 14.5%, others at 15.0%. A value of 14.8% at a lab whose cutoff is 14.5% is technically flagged but may not mean much on its own. Your doctor will weigh it against your hemoglobin, MCV, and the rest of the complete blood count before deciding whether to investigate further.

Common Reasons RDW-CV Is Elevated

An elevated RDW-CV means your blood contains a mix of red blood cells that vary more in size than expected. The list of conditions that can cause this is long, but a few categories cover most cases.

Nutrient Deficiencies

Iron deficiency anemia is the most common reason for a high RDW-CV worldwide. When iron stores run low, the bone marrow starts producing smaller-than-normal red blood cells (microcytes), while older, normal-sized cells are still circulating. That mismatch pushes RDW-CV up. Research has found that the worse the iron deficiency, the higher the RDW-CV tends to climb: patients with iron deficiency anemia averaged an RDW of about 18.2%, and an RDW above 17.1% strongly suggested the diagnosis.⁴ Folate and vitamin B12 deficiencies work in the opposite direction, producing abnormally large cells (macrocytes) while normal-sized cells persist, but the effect on RDW-CV is the same: more variation, higher number.

Inherited Blood Disorders

Conditions like beta-thalassemia, sickle cell disease, and hereditary spherocytosis can all push RDW-CV above the normal range.⁵ In non-transfusion-dependent thalassemia, one study found a mean RDW of about 24.5%, well above the roughly 20% seen in iron deficiency anemia patients in the same cohort.⁶ This is partly why RDW-CV is useful in telling apart thalassemia trait from iron deficiency: both produce small red blood cells, but the degree of size variation differs.

Chronic Disease, Inflammation, and Oxidative Stress

Conditions like chronic kidney disease, heart failure, liver disease, and chronic infections can raise RDW-CV even without an obvious anemia. The proposed mechanism is that oxidative stress and chronic inflammation suppress normal red blood cell production in the bone marrow and shorten the lifespan of circulating cells, leading to a jumble of cell sizes.⁷ Blood transfusions, some hemolytic anemias, and impaired kidney function are also on the list of causes.⁵

Using RDW-CV to Tell Anemias Apart

One of the most practical uses of RDW-CV is in the early workup of anemia, specifically sorting out which type you have before ordering more expensive or invasive tests. The classic pairing is RDW-CV with MCV. Iron deficiency anemia typically shows a low MCV (small cells) and a high RDW-CV (lots of size variation). Anemia of chronic disease also tends to produce small or normal-sized cells, but the RDW-CV often stays closer to normal because the cells, while possibly small, are uniformly so.

In one study, combining MCV and RDW correctly classified iron deficiency anemia in about 83% of cases and anemia of chronic disorders in about 90% of cases. An MCV-to-RDW ratio below 5.1 identified iron deficiency anemia with roughly 86% sensitivity and 87% specificity.⁸ These numbers are not perfect, but for a test that comes free as part of every complete blood count, the diagnostic value is hard to beat.

The same logic applies to the thalassemia question. Both iron deficiency and beta-thalassemia trait produce small red blood cells, and in parts of the world where both conditions are common, telling them apart quickly matters for treatment decisions. An RDW-CV above 21% pointed toward non-transfusion-dependent thalassemia with about 81% sensitivity in one cohort, while iron deficiency patients clustered at lower RDW-CV values.⁶

RDW-CV as a Predictor of Serious Outcomes

Over the past fifteen years, research has increasingly shown that RDW-CV predicts more than just anemia. Higher values are linked to worse outcomes across a wide range of conditions, even after accounting for other risk factors.

In a large community-based study of middle-aged and older adults, people with RDW values in the highest brackets had roughly two to three times the risk of dying from cardiovascular disease compared to those in the lowest bracket, and adjusting for traditional risk factors did not substantially weaken this association.⁹ Another general-population analysis found RDW was significantly associated with cancer mortality, cardiovascular mortality, and respiratory disease mortality when comparing the top quartile to the bottom quartile.¹⁰

The pattern extends to acute settings. In patients who had recently experienced an acute coronary syndrome, each 1% increase in baseline RDW-CV was independently associated with higher risk of major cardiovascular events and death.¹¹ In elderly patients with sepsis, the non-survival group had a mean RDW-CV of about 17.2% compared with roughly 15.3% in survivors. Researchers incorporated RDW-CV into a scoring tool alongside other clinical indicators and found it contributed meaningfully to predicting who would not survive.¹²

Why does a measure of red blood cell size variation predict heart attacks and cancer deaths? Nobody is entirely sure. The leading explanation ties it back to chronic inflammation and oxidative stress. Both processes damage red blood cell production and accelerate cell destruction, driving up RDW-CV. But the same inflammatory pathways also promote atherosclerosis, tumor growth, and organ damage.⁷ In other words, RDW-CV may not cause bad outcomes; it may simply be a sensitive barometer of how much systemic stress your body is under.

RDW-CV and Kidney Disease

Chronic kidney disease deserves its own mention because RDW-CV has been studied extensively in this population. Kidneys produce erythropoietin, the hormone that stimulates red blood cell production, so it makes biological sense that kidney damage would disrupt cell size uniformity. In patients with chronic kidney disease, a high RDW-CV has been associated with a dramatically increased risk of rapid kidney function decline, with one study reporting roughly seven times the odds of rapid renal function loss in those with elevated values.¹³ RDW-CV also predicted cardiovascular events in this group, which matters because heart disease is the leading cause of death in people with chronic kidney disease.⁷

For patients on dialysis, a single hemodialysis session does not meaningfully change RDW-CV. Both RDW-CV and RDW-SD reflect chronic disease status rather than something that bounces around with each treatment.³ That stability is actually useful: it means a high RDW-CV is a durable marker of how the disease is affecting your blood, not a blip from yesterday’s treatment.

How Pregnancy Changes RDW-CV

If you are pregnant and see a flagged RDW-CV on your lab work, it may not indicate a problem. Pregnancy naturally shifts red blood cell dynamics. A systematic review found that the median RDW-CV was significantly higher in pregnant women than in non-pregnant women (about 13.5% versus 12.3%), and the value tends to rise further as pregnancy progresses.¹⁴ By the third trimester, more than a third of healthy pregnant women in one study had an RDW-CV above 15%, which would be flagged as abnormal by standard non-pregnant reference ranges.¹⁴

The likely explanations are increased bone marrow activity to keep up with the expanding blood volume, plus the higher incidence of mild iron deficiency as the fetus draws on maternal stores. There is also a sharp increase in RDW between roughly 34 weeks of gestation and the onset of labor.¹⁵ The takeaway for pregnant readers: your doctor should interpret RDW-CV against pregnancy-specific reference intervals, not the standard adult ones. A value of 16% in the third trimester is probably normal; the same number in a non-pregnant adult warrants a closer look.

RDW-CV in Newborns and Children

Newborns have naturally higher RDW-CV values than adults, and premature babies have the highest of all. At birth, the lower reference limit for term and late preterm neonates is about 15.5%, and the upper limit is around 20%, with premature infants reaching as high as 23%.¹⁶ Mean RDW values in very preterm babies (32 to 34 weeks) are higher than in those born closer to term, and values at very early gestational ages tend to be higher still.¹⁷

The reason is straightforward: fetal and neonatal red blood cells are produced under different conditions and pressures than adult cells. The switch from fetal hemoglobin to adult hemoglobin, the rapid growth of blood volume, and the relatively immature bone marrow all contribute to wider size variation. Extremely high values at birth (above roughly 29%) have been associated with prenatal hemorrhage or hemolysis, while very low values (below about 14%) at birth tended to coincide with unusually small red blood cells.¹⁶ Pediatricians use age-specific reference ranges to avoid mistaking normal neonatal variation for a blood disorder.

How Aging Affects Your RDW-CV

Even in healthy people without anemia or chronic disease, RDW-CV creeps upward with age. A large study of over 8,000 individuals found a strong association between RDW and age but not with gender. The conventional RDW-CV increased by about 6% from the youngest to the oldest age group, while RDW-SD rose by nearly 15%.¹⁸ MCV also tended to rise across the age span. The practical implication is that a 75-year-old with an RDW-CV of 15.0% may be perfectly healthy, while the same value in a 25-year-old is more likely to signal something worth investigating. Some researchers have argued that age-adjusted reference ranges should be standard, but most labs still use a single adult cutoff.

Blood Transfusions and RDW-CV Spikes

If you have recently received a blood transfusion and notice your RDW-CV has jumped, the transfusion itself is probably the explanation. When donor red blood cells are mixed with a patient’s own cells, the combined pool often has greater size variation than either set alone. In a study of critically ill patients, RDW increased significantly after transfusion, peaking shortly after the infusion. Before transfusion, about 72% of patients had an abnormal RDW value; afterward, that figure rose to 94%.¹⁹ The biggest jumps occurred when the difference between the donor’s MCV and the patient’s MCV was largest, especially in patients whose own cells were either much smaller or much larger than average.¹⁹

A much larger analysis of over 1,500 emergency surgery patients found only a very weak correlation between the number of transfused red blood cell units and the change in RDW from admission to discharge, with transfused units explaining less than 1% of the variation in RDW.²⁰ So while transfusions can cause a short-term spike, the bigger picture of a patient’s RDW-CV trajectory over a hospital stay is driven more by underlying disease than by the transfusions themselves. This distinction matters because clinicians increasingly use trending RDW-CV values during hospitalization as a prognostic clue. A post-transfusion bump should be interpreted cautiously rather than taken as evidence that a patient is getting sicker.

What to Do if Your RDW-CV Is High

A single elevated RDW-CV on a routine blood count is not, by itself, a reason to panic. The number is a starting point for a conversation, not a final answer. Your doctor will look at the rest of your complete blood count, especially hemoglobin, MCV, and platelet count, to figure out what the elevated RDW-CV is pointing toward. In many cases, the next step is checking iron, ferritin, folate, and vitamin B12 levels. If those come back normal, your doctor may consider inflammatory markers or kidney function tests.

For the most common cause, iron deficiency, the fix is often straightforward: dietary changes, iron supplements, or identifying and treating the source of iron loss (heavy periods, gastrointestinal bleeding, poor absorption). Once iron stores are replenished and new, normally sized red blood cells replace the old mismatched population, RDW-CV drifts back to normal over weeks to months. For chronic conditions like kidney disease or heart failure, RDW-CV serves more as a monitoring tool. A rising value over serial blood draws can alert your care team that the disease is worsening or that treatment needs adjusting, while a stable or declining value is reassuring.

If your RDW-CV is elevated and your doctor is not concerned, it is reasonable to ask why. You might be pregnant, recently transfused, elderly, or mildly iron-deficient in a way that does not yet require intervention. Understanding what the number means, and what it does not mean, keeps you from over-interpreting a single data point on a lab report that was designed to be read as a whole.

1
SpringerOpen. Red Blood Cells Mean Corpuscular Volume (MCV) and Red Blood Distribution Width (RDW) Parameters as Potential Indicators of Regenerative Potential in Older Patients and Predictors of Acute Mortality – Preliminary Report
2
Clinical Chemistry. A Review of RDW-CV and RDW-SD Measurements in Patients With Iron Deficiency Anemia in an Acute Care Hospital in Singapore
3
AVERROUS: Jurnal Kedokteran dan Kesehatan Malikussaleh. Comparison of RDW-SD and RDW-CV in Chronic Kidney Disease Patients Before and After Hemodialysis
4
PubMed. Red cell distribution width as a measure of severity of iron deficiency in iron deficiency anaemia
5
PubMed Central. Red blood cell distribution width: A marker of anisocytosis potentially associated with atrial fibrillation
6
PubMed Central. The role of red cell distribution width in the differential diagnosis of iron deficiency anemia and non-transfusion-dependent thalassemia patients
7
PubMed Central. Red cell distribution width associated with adverse cardiovascular outcomes in patients with chronic kidney disease
8
Blood Research. Diagnostic Significance of RDW and MCV in Iron Deficiency Anemia and Anemia of Chronic Disorders
9
PubMed Central. Red Cell Distribution Width and the Risk of Death in Middle-aged and Older Adults
10
Scientific Reports. The relationship between red cell distribution width and all-cause and cause-specific mortality in a general population
11
PubMed. Relation of red blood cell distribution width to risk of major adverse cardiovascular events, death, and effect of alirocumab after acute coronary syndromes
12
PubMed Central. A Practical Nomogram Based on RDW-CV for Predicting Clinical Outcome in Elderly Septic Patients
13
PubMed Central. Red Blood Cell Distribution Width Is Associated With Adverse Kidney Outcomes in Patients With Chronic Kidney Disease
14
PubMed Central. Red blood cell distribution width in pregnancy: a systematic review
15
PubMed. Red cell distribution width changes in pregnancy
16
PubMed. Red blood cell distribution width: reference intervals for neonates
17
PubMed Central. Red cell distribution width (RDW) in the newborn: normative data
18
PubMed. Effect of age and gender on reference intervals of red blood cell distribution width (RDW) and mean red cell volume (MCV)
19
PubMed. The effects of blood transfusion on red blood cell distribution width in critically ill patients: a pilot study
20
Journal of Trauma and Acute Care Surgery. Red cell distribution width predicts out of hospital outcomes in critically ill emergency general surgery patients